Skip to content

Absci Corporation ABSI Stock-Based Comp

Stock-Based Comp at other companies

Schrodinger logo
SchrodingerSDGR
$9.07M-21.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$22.22M-38.4%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$12.81M+44.6%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$12.01M-18.8%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$14.22M+55.0%
ADMA Biologics logo
ADMA BiologicsADMA
$6.33M+36.9%

Segments

By segment

See full
Segment One$4.38M-11.4%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's stock-based comp?
Absci Corporation (ABSI) reported stock-based comp of $4.38M in Q1 2026.
How has Absci Corporation's stock-based comp changed year-over-year?
Absci Corporation's stock-based comp decreased by 10.8% year-over-year, from $4.91M to $4.38M.
What is the long-term trend for Absci Corporation's stock-based comp?
Over 4 years (2021 to 2025), Absci Corporation's stock-based comp has grown at a 14.6% compound annual growth rate (CAGR), from $10.61M to $18.32M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.